Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

The Role of Extrahepatic Metabolism in the Pharmacokinetics of the Targeted Covalent Inhibitors Afatinib, Ibrutinib, and Neratinib

Yoshihiro Shibata and Masato Chiba
Drug Metabolism and Disposition March 2015, 43 (3) 375-384; DOI: https://doi.org/10.1124/dmd.114.061424
Yoshihiro Shibata
Discovery Drug Metabolism and Pharmacokinetics, Pharmacokinetics Research Laboratories, Tsukuba Research Center, Taiho Pharmaceutical Co. Ltd., Ibaraki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masato Chiba
Discovery Drug Metabolism and Pharmacokinetics, Pharmacokinetics Research Laboratories, Tsukuba Research Center, Taiho Pharmaceutical Co. Ltd., Ibaraki, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 43 no. 3 375-384
DOI 
https://doi.org/10.1124/dmd.114.061424
PubMed 
25504185

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received September 30, 2014
  • Accepted December 10, 2014
  • Published online January 24, 2015.

Article Versions

  • Earlier version (December 10, 2014 - 07:18).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Yoshihiro Shibata and
  2. Masato Chiba
  1. Discovery Drug Metabolism and Pharmacokinetics, Pharmacokinetics Research Laboratories, Tsukuba Research Center, Taiho Pharmaceutical Co. Ltd., Ibaraki, Japan
  1. Address correspondence to:
    Dr. Yoshihiro Shibata, Discovery Drug Metabolism and Pharmacokinetics, Pharmacokinetics Research Laboratories, Tsukuba Research Center, Taiho Pharmaceutical Co. Ltd., 3 Okubo, Tsukuba, Ibaraki 300-2611, Japan. E-mail: yoshi-shibata{at}taiho.co.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: December 2014 to February 2021

AbstractFullPdf
Dec 20143910179
Jan 201552120174
Feb 201564848239
Mar 201532338101
Apr 20151612462
May 20151352242
Jun 20151141545
Jul 2015912743
Aug 2015524135
Sep 2015893034
Oct 2015672129
Nov 2015734661
Dec 2015751833
Jan 2016603458
Feb 2016434679
Mar 2016515274
Apr 2016596251
May 2016515569
Jun 2016363859
Jul 2016433467
Aug 2016434671
Sep 2016305758
Oct 2016126934
Nov 2016115871
Dec 201664341
Jan 201765644
Feb 201777057
Mar 201796869
Apr 201795264
May 2017216884
Jun 2017156971
Jul 2017145279
Aug 201793942
Sep 2017116185
Oct 2017158361
Nov 2017108063
Dec 2017175444
Jan 201869573
Feb 2018199190
Mar 201877571
Apr 2018146459
May 201896240
Jun 2018147875
Jul 201866243
Aug 2018134836
Sep 2018510561
Oct 20181512139
Nov 20182015348
Dec 2018210829
Jan 20192114549
Feb 20191512848
Mar 201977632
Apr 2019125349
May 201927032
Jun 201994938
Jul 201974932
Aug 2019114749
Sep 201945960
Oct 2019166250
Nov 201958038
Dec 201984247
Jan 2020117748
Feb 2020114544
Mar 202065851
Apr 2020127452
May 202065357
Jun 2020910149
Jul 202056849
Aug 202074043
Sep 2020108848
Oct 202075857
Nov 2020148265
Dec 2020165231
Jan 2021253928
Feb 20211112626

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 43 (3)
Drug Metabolism and Disposition
Vol. 43, Issue 3
1 Mar 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Role of Extrahepatic Metabolism in the Pharmacokinetics of the Targeted Covalent Inhibitors Afatinib, Ibrutinib, and Neratinib
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Pharmacokinetics of Targeted Covalent Inhibitors

Yoshihiro Shibata and Masato Chiba
Drug Metabolism and Disposition March 1, 2015, 43 (3) 375-384; DOI: https://doi.org/10.1124/dmd.114.061424

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Pharmacokinetics of Targeted Covalent Inhibitors

Yoshihiro Shibata and Masato Chiba
Drug Metabolism and Disposition March 1, 2015, 43 (3) 375-384; DOI: https://doi.org/10.1124/dmd.114.061424
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • In Vivo Functional Effects of CYP2C9 M1L
  • Clearance pathways: fevipiprant with probenecid perpetrator
  • Predicting Volume of Distribution from In Vitro Parameters
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics